# Antibiotic medicines: Interventions

Source page: https://www.materialinsights.org/products/p_antibiotic_medicines/prod-interventions/

#### Interventions

Changes that would cut emissions or material use, by lever and life stage, with effect per unit, readiness, adoption, evidence and who acts

| Lever | Life stage | Change | Effect per unit | Readiness | Adoption | Who acts | Source |
|---|---|---|---|---|---|---|---|
| Use less | Use | Cut antibiotic prescribing that is not needed | In NHS England the recommended 20% cut in antibiotic prescribing could save 4,200 tonnes CO2e a month (modelled, whole system, not per course) | Modelled | Not stated | Prescribers, health systems, regulators | ^[9] |
| Substitute | Use | Prevent infections with vaccines so that fewer antibiotics are needed | WHO estimates vaccines against 23 pathogens, some still to be developed, could cut the antibiotics needed by 22%, or 2.5 billion defined daily doses a year; vaccines already in use against three of them could avert up to 106,000 deaths associated with resistance a year | Deployed for existing vaccines; others still to be developed | Not stated | Ministries of health, Gavi, vaccine makers | ^[21] |
| Substitute | Use | Shift use toward Access antibiotics | The UN target is at least 70% of antibiotic use from the Access group by 2030; no per-course saving is stated | Target adopted in 2024 | Only one in three reporting countries, territories and areas met it on 2022 data | Ministries of health, prescribers, procurers | ^[8] |
| Change route | Making | Control antibiotic pollution from factories | WHO's 2024 guidance gives human health-based targets and targets for risks to aquatic life; India's January 2020 draft limits were derived from resistance-selection thresholds, but a press report says the final 2021 standards dropped them; no per-course saving is stated | WHO guidance published in 2024; India's antibiotic limits not in its final 2021 standards, as reported | Not stated | Regulators, manufacturers, procurers | ^[1]^[18]^[28] |
| Business model | Supply chain | Build penicillin and intermediate capacity outside China | India approved penicillin G (Rs 1,392 crore committed) and 7-ACA (Rs 813 crore committed) plants in 2021, and Aurobindo commissioned a 15,000-tonne-a-year penicillin G plant and a 6-APA plant in 2024; Sandoz put EUR 200 million into Kundl; no emissions effect is stated | Penicillin G plant commissioned in April 2024 and restarted in July 2025 after a fire; the 7-ACA plant's status was not found | Not stated | Governments, Aurobindo, KAPL, Sandoz | ^[16]^[25]^[26]^[15] |

as of 2026-11-14

#### Sources

1. [New global guidance aims to curb antibiotic pollution from manufacturing](https://www.who.int/news/item//03-09-2024-new-global-guidance-aims-to-curb-antibiotic-pollution-from-manufacturing) World Health Organization, 2024, news release of 3 September 2024
2. [Antibiotics most responsible for drug resistance are overused - WHO report](https://www.who.int/news/item/29-04-2025-antibiotics-most-responsible-for-drug-resistance-are-overused---who-report) World Health Organization, 2025, news release of 29 April 2025; 2022 data
3. [MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale](https://pubmed.ncbi.nlm.nih.gov/39284639/) British Journal of Clinical Pharmacology 90(11): 2713-2723 (Taylor, Mahamdallie, Sawyer, Rahman; record on PubMed), 2024, abstract; NHS England prescribed doses of January 2023
4. [Sandoz opens antibiotic production facility in Austria](https://chemanager-online.com/en/news/sandoz-opens-antibiotic-production-facility-in-austria) CHEManager International, 2024, 26 March 2024; company claims reported by a trade publication
5. [Aurobindo Pharma, KAPL get approval for promotion of manufacturing bulk drugs](https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-kapl-get-approval-for-promotion-of-manufacturing-bulk-drugs-73830) Medical Dialogues, 2021, 24 January 2021, by Ruchika Sharma, citing PTI and a Ministry of Chemicals and Fertilizers statement
6. [The Indian government publish draft legislation to limit antibiotic pollution from manufacturing](https://www.gu.se/en/news/the-indian-government-publish-draft-legislation-to-limit-antibiotic-pollution-from-manufacturing) University of Gothenburg, 2020, 13 February 2020; the notification number and date appear only in the page's link
7. [Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO](https://www.who.int/news/item/10-10-2024-better-use-of-vaccines-could-reduce-antibiotic-use-by-2.5-billion-doses-annually--says-who) World Health Organization, 2024, 10 October 2024; corrected on 24 October 2024 to 23 pathogens
8. [Aurobindo Pharma commissions 4 manufacturing plants for PenicillinG, other products](https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-commissions-4-manufacturing-plants-for-penicilling-other-products-126567) Medical Dialogues (Ruchika Sharma), 2024, 1 April 2024
9. [Aurobindo Pharma arm restarts production at Kakinada Penicillin-G plant after fire incident](https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-arm-restarts-production-at-kakinada-penicillin-g-plant-after-fire-incident-150927) Medical Dialogues (Ruchika Sharma), 2025, 1 July 2025
10. [Green Ministry drops Antibiotic effluent limits from new rules](https://thehealthmaster.com/?p=27104) The Health Master (from ET Healthworld), 2021, 14 August 2021; secondhand press report

## Other sections

- [Summary](https://www.materialinsights.org/products/p_antibiotic_medicines/index.md)
- [Working](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-working/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-bom/index.md)
- [Use case](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-evolution/index.md)
